Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
- 2019/07/17Adocia Presents First Half 2019 Financial Results
- 2019/07/11Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
- September 10-16, 2019 55th annual meeting of the European Association for the Study of Diabetes, Barcelona, Spain